Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001213900-26-064294
- form_type
- 8-K
- ticker
- null
- cik
- 0001845459
- company_name
- NKGen Biotech, Inc.
- filed_at
- 2026-06-02T21:20:15+00:00
- discovered_at
- 2026-06-02T21:22:00.302653+00:00
- generated_at
- 2026-06-02T21:22:39.997911+00:00
- sec_items
- ["1.01", "2.03", "3.02", "9.01"]
- event_type
- debt
- sentiment
- neutral
- materiality_score
- 0.65
- calibrated_materiality_score
- 0.65
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001213900-26-064294
- json_url
- https://secwatch.observer/filing/0001213900-26-064294.json
- markdown_url
- https://secwatch.observer/filing/0001213900-26-064294.md
- text_url
- https://secwatch.observer/filing/0001213900-26-064294.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1845459/000121390026064294/0001213900-26-064294-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1845459/000121390026064294/ea0292593-8k_nkgen.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
BTU
Peabody prices $250M convertible notes due 2031, repurchases $241.2M of 2028 notes
PEABODY ENERGY CORP
June 2, 2026, 10:17 AM ET
debt
Items 1.01, 2.03, 3.02, 9.01
same fact type: material_agreement
same SEC item: 1.01, 2.03, 3.02, 9.01
same event type: debt
similar materiality
This filing
On May 27, 2026, NKGen Biotech, Inc., a Delaware corporation (the “ Company ”), and NKGen Operating Biotech, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ NKGen OpCo ,” and together with the Company, the “ Borrowers ”), entered into a Third Omnibus Amendment to Secured Convertible Loan Agreement and Warrants (the “ Third Amendment ”) with AlpineBrook Capital GP I Limited (the “ Lender ”).
Comparable filing
Convertible Notes and the Indenture On May 28, 2026, Peabody Energy Corporation (the “Company” or “Peabody”) priced its private offering of $225 million in aggregate principal amount of 0.50% Convertible Senior Notes due 2031 (the “Initial Notes”).
Filing page
SEC filing
CBLO
C2 Blockchain raises $130K and up to $1.2M via convertible notes with heavy dilution
C2 Blockchain, Inc.
June 2, 2026, 10:08 AM ET
debt
Items 1.01, 2.03, 3.02, 9.01
same fact type: material_agreement
same SEC item: 1.01, 2.03, 3.02, 9.01
same event type: debt
similar materiality
This filing
On May 27, 2026, NKGen Biotech, Inc., a Delaware corporation (the “ Company ”), and NKGen Operating Biotech, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ NKGen OpCo ,” and together with the Company, the “ Borrowers ”), entered into a Third Omnibus Amendment to Secured Convertible Loan Agreement and Warrants (the “ Third Amendment ”) with AlpineBrook Capital GP I Limited (the “ Lender ”).
Comparable filing
On May 28, 2026, the Company entered into a Securities Purchase Agreement with Leonite Fund I, LP (“Leonite”), pursuant to which the Company issued and sold a Senior Secured Convertible Promissory Note having an aggregate principal amount of up to $1,200,000 (the “Leonite Note”).
Filing page
SEC filing
EMAT
EMAT secures $100M convertible debenture facility from Yorkville; first $20M tranche issued
Evolution Metals & Technologies Corp.
May 11, 2026, 7:59 PM ET
debt
Items 1.01, 2.03, 3.02, 7.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 2.03, 3.02, 9.01
same event type: debt
similar materiality
This filing
On May 27, 2026, NKGen Biotech, Inc., a Delaware corporation (the “ Company ”), and NKGen Operating Biotech, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ NKGen OpCo ,” and together with the Company, the “ Borrowers ”), entered into a Third Omnibus Amendment to Secured Convertible Loan Agreement and Warrants (the “ Third Amendment ”) with AlpineBrook Capital GP I Limited (the “ Lender ”).
Comparable filing
On May 7, 2026, Evolution Metals & Technologies Corp. (“EMAT” or the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with YA II PN, LTD. (“Yorkville”), a fund managed by Yorkville Advisors Global, LP, pursuant to which the Company agreed to issue and sell to Yorkville convertible debentures in the aggregate principal amount of up to $100,000,000
Filing page
SEC filing
TBH
Brag House issues $2.5M convertible notes at 25% OID; proceeds for House of Doge merger
Brag House Holdings, Inc.
May 8, 2026, 7:59 PM ET
debt
Items 1.01, 2.03, 3.02, 9.01
same fact type: material_agreement
same SEC item: 1.01, 2.03, 3.02, 9.01
same event type: debt
similar materiality
This filing
On May 27, 2026, NKGen Biotech, Inc., a Delaware corporation (the “ Company ”), and NKGen Operating Biotech, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ NKGen OpCo ,” and together with the Company, the “ Borrowers ”), entered into a Third Omnibus Amendment to Secured Convertible Loan Agreement and Warrants (the “ Third Amendment ”) with AlpineBrook Capital GP I Limited (the “ Lender ”).
Comparable filing
In connection with the Offering, on May 4, 2026, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Purchasers.
Filing page
SEC filing
KNX
Knight-Swift closes $1.5B convertible note offering at 1.00% due 2031; proceeds used to repay term loans and revolver
Knight-Swift Transportation Holdings Inc.
May 8, 2026, 7:59 PM ET
debt
Items 1.01, 2.03, 3.02, 8.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 2.03, 3.02, 9.01
same event type: debt
similar materiality
This filing
On May 27, 2026, NKGen Biotech, Inc., a Delaware corporation (the “ Company ”), and NKGen Operating Biotech, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ NKGen OpCo ,” and together with the Company, the “ Borrowers ”), entered into a Third Omnibus Amendment to Secured Convertible Loan Agreement and Warrants (the “ Third Amendment ”) with AlpineBrook Capital GP I Limited (the “ Lender ”).
Comparable filing
On May 8, 2026, Knight-Swift Transportation Holdings Inc. (the "Company") completed its previously announced private offering (the "Offering") of $1.5 billion aggregate principal amount of 1.00% Convertible Senior Notes due 2031 (the "Notes"), including the exercise in full of the initial purchasers' option to purchase up to an additional $200.0 million principal amount of the Notes.
Filing page
SEC filing
WS
Worthington Steel prices $700M 7.75% notes due 2033 and $700M term loan for Klöckner acquisition
Worthington Steel, Inc.
June 2, 2026, 5:06 PM ET
debt
Items 1.01, 2.03, 8.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
This filing
On May 27, 2026, NKGen Biotech, Inc., a Delaware corporation (the “ Company ”), and NKGen Operating Biotech, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ NKGen OpCo ,” and together with the Company, the “ Borrowers ”), entered into a Third Omnibus Amendment to Secured Convertible Loan Agreement and Warrants (the “ Third Amendment ”) with AlpineBrook Capital GP I Limited (the “ Lender ”).
Comparable filing
On June 1, 2026, the Company issued $700,000,000 aggregate principal amount of its 7.750% Senior Secured Notes due 2033 (the " Notes ," and such offering, the " Note Offering ") pursuant to an indenture (the " Indenture "), dated as of June 1, 2026, among the Company, as issuer, the guarantors from time to time party thereto (the " Note Guarantors ") and Deutsche Bank Trust Company Americas, as trustee and notes collateral agent.
Filing page
SEC filing
USFD
US Foods upsizes ABL facility to $2.5B and extends maturity to 2031
US Foods Holding Corp.
June 2, 2026, 4:58 PM ET
debt
Items 1.01, 2.03, 9.01
same fact type: material_agreement
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
This filing
On May 27, 2026, NKGen Biotech, Inc., a Delaware corporation (the “ Company ”), and NKGen Operating Biotech, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ NKGen OpCo ,” and together with the Company, the “ Borrowers ”), entered into a Third Omnibus Amendment to Secured Convertible Loan Agreement and Warrants (the “ Third Amendment ”) with AlpineBrook Capital GP I Limited (the “ Lender ”).
Comparable filing
On May 28, 2026, US Foods, Inc. (“US Foods”) entered into an amendment (the “Amendment”) to its existing ABL Credit Agreement, dated as of May 31, 2019, as amended, restated, modified or supplemented from time to time, by and among US Foods, the other Loan Parties (defined in the ABL Agreement), each lender and issuing lender from time to time party thereto, and Wells Fargo Bank, National Association, as administrative agent and collateral agent (the “ABL Agreement”).
Filing page
SEC filing
HTZ
Hertz issues $1B asset-backed notes via HVF III at rates 5.09%-10.67%
HERTZ GLOBAL HOLDINGS, INC
June 2, 2026, 4:42 PM ET
debt
Items 1.01, 2.03, 9.01
same fact type: material_agreement
same SEC item: 1.01, 2.03, 9.01
same event type: debt
similar materiality
This filing
On May 27, 2026, NKGen Biotech, Inc., a Delaware corporation (the “ Company ”), and NKGen Operating Biotech, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ NKGen OpCo ,” and together with the Company, the “ Borrowers ”), entered into a Third Omnibus Amendment to Secured Convertible Loan Agreement and Warrants (the “ Third Amendment ”) with AlpineBrook Capital GP I Limited (the “ Lender ”).
Comparable filing
(2) the Series 2026-2 Fixed Rate Rental Car Asset Backed Notes, Class A, Class B, Class C, Class D, and Class E, in an aggregate principal amount equal to $500,000,000, pursuant to the Series 2026-2 Supplement (the “ Series 2026-2 Supplement ”), dated as of May 28, 2026, among HVF III, as issuer, THC, as administrator, and BNYM, as trustee, to the Base Indenture
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.